Small Cell Lung Cancer Clinical Trials
0 recruiting
Showing 1–20 of 42 trials
Recruiting
Phase 2
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
AbbVie180 enrolled16 locationsNCT07155174
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Small Cell Lung Cancer
Merck Sharp & Dohme LLC262 enrolled45 locationsNCT06780137
Recruiting
Phase 3
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Small Cell Lung Cancer
Akeso560 enrolled53 locationsNCT07010263
Recruiting
Phase 1
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Breast CancerGastric CancerOvarian Cancer+1 more
BeiGene258 enrolled24 locationsNCT06257264
Recruiting
Phase 3
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Daiichi Sankyo540 enrolled230 locationsNCT06203210
Recruiting
Phase 3
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
Small Cell Lung CancerLimited Stage Small Cell Lung Cancer
Amgen400 enrolled204 locationsNCT06117774
Recruiting
DESTINY-PANTUMOUR04
Liver CancerEsophageal CancerPancreatic Cancer+24 more
AstraZeneca100 enrolled15 locationsNCT07124000
Recruiting
Phase 1
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Breast CancerOvarian CancerCancer+4 more
Conjupro Biotherapeutics, Inc.386 enrolled1 locationNCT07424547
Recruiting
Phase 2
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
Puma Biotechnology, Inc.80 enrolled30 locationsNCT06095505
Recruiting
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
Small Cell Lung Cancer
Tempus AI50 enrolled11 locationsNCT05257551
Recruiting
Phase 1
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer
Amgen200 enrolled36 locationsNCT06898957
Recruiting
Phase 2
A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
Small Cell Lung Cancer
China Medical University, China36 enrolled1 locationNCT07373964
Recruiting
Phase 1
Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma
Small Cell Lung Cancer
Centre Antoine Lacassagne27 enrolled2 locationsNCT03467360
Recruiting
Phase 1Phase 2
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
Small Cell Lung CancerSmall Cell Lung Carcinoma
Memorial Sloan Kettering Cancer Center53 enrolled1 locationNCT04199741
Recruiting
Phase 1Phase 2
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd54 enrolled1 locationNCT05978284
Recruiting
Phase 1Phase 2
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd350 enrolled1 locationNCT07038096
Recruiting
Phase 1
ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Small Cell Lung Cancer
SciTech Development, Inc.44 enrolled1 locationNCT06922539
Recruiting
Phase 1Phase 2
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
Small Cell Lung CancerNeuroendocrine Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd265 enrolled1 locationNCT06283719
Recruiting
Phase 1
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Nerviano Medical Sciences10 enrolled2 locationsNCT06931626
Recruiting
Phase 2
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.100 enrolled1 locationNCT05924841